Song, Y., Ma, J., Zhang, H., Xie, Y., Peng, Z., Shuang, Y., Li, F., Li, Y., Yang, H., Zou, L., Sun, X., Zhao, W., Huang, W., Huang, Y., Zhou, H., Wang, Y., Wang, W., Xu, J., Deng, R., Meng, Q., Zhu, J. (2025). Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trial. Nature Communications. https://doi.org/10.1038/s41467-025-59461-3